S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in

STERIS plc (NYSE:STE) Receives Consensus Recommendation of "Hold" from Analysts

Last updated on Tuesday, February 23, 2021 | 2021 MarketBeat

Shares of STERIS plc (NYSE:STE) have received a consensus recommendation of "Hold" from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating on the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $202.40.

Several research firms have commented on STE. Robert W. Baird lifted their price objective on shares of STERIS from $200.00 to $230.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 13th. Raymond James reissued a "hold" rating on shares of STERIS in a research note on Wednesday, January 20th. KeyCorp raised shares of STERIS from a "sector weight" rating to an "overweight" rating and set a $224.00 target price for the company in a research note on Thursday, February 4th. Finally, Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research note on Friday, November 20th.

NYSE STE opened at $175.62 on Tuesday. The company has a quick ratio of 2.00, a current ratio of 2.64 and a debt-to-equity ratio of 0.28. The company has a fifty day moving average of $188.09 and a two-hundred day moving average of $180.29. The firm has a market capitalization of $14.99 billion, a price-to-earnings ratio of 35.62 and a beta of 0.59. STERIS has a 52 week low of $105.69 and a 52 week high of $203.90.

STERIS (NYSE:STE) last posted its quarterly earnings data on Tuesday, February 2nd. The medical equipment provider reported $1.73 EPS for the quarter, topping the consensus estimate of $1.52 by $0.21. The company had revenue of $808.90 million during the quarter, compared to analyst estimates of $794.08 million. STERIS had a net margin of 13.97% and a return on equity of 14.44%. STERIS's quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.45 earnings per share. Equities research analysts anticipate that STERIS will post 6.03 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 25th. Investors of record on Wednesday, February 24th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date is Tuesday, February 23rd. STERIS's dividend payout ratio (DPR) is presently 28.37%.

In related news, Director David B. Lewis sold 1,560 shares of the company's stock in a transaction dated Tuesday, December 1st. The shares were sold at an average price of $193.79, for a total value of $302,312.40. Following the completion of the sale, the director now directly owns 8,244 shares of the company's stock, valued at $1,597,604.76. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Julia Madsen sold 1,000 shares of the company's stock in a transaction dated Friday, January 8th. The stock was sold at an average price of $202.00, for a total transaction of $202,000.00. 1.20% of the stock is owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in STE. Polar Capital LLP bought a new position in STERIS in the third quarter worth about $38,483,000. Massachusetts Financial Services Co. MA raised its holdings in STERIS by 6.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,021,523 shares of the medical equipment provider's stock worth $532,363,000 after purchasing an additional 194,134 shares in the last quarter. Alliancebernstein L.P. raised its holdings in STERIS by 21.3% in the fourth quarter. Alliancebernstein L.P. now owns 1,072,411 shares of the medical equipment provider's stock worth $203,265,000 after purchasing an additional 188,412 shares in the last quarter. WCM Investment Management LLC raised its holdings in STERIS by 2.7% in the third quarter. WCM Investment Management LLC now owns 6,468,936 shares of the medical equipment provider's stock worth $1,139,762,000 after purchasing an additional 167,891 shares in the last quarter. Finally, Williams Jones Wealth Management LLC. raised its holdings in STERIS by 35.0% in the third quarter. Williams Jones Wealth Management LLC. now owns 604,324 shares of the medical equipment provider's stock worth $106,476,000 after purchasing an additional 156,673 shares in the last quarter. Institutional investors and hedge funds own 90.01% of the company's stock.

About STERIS

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

See Also: Calculating net profit and net profit margin ratio

Analyst Recommendations for STERIS (NYSE:STE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]


7 Infrastructure Stocks That May Help Rebuild America

Despite their disagreements (real or imagined) on almost everything, Democrats and Republicans alike love infrastructure projects. These are easy wins for Congressional leaders seeking re-election. And they typically spur job creation, which contributes to economic growth.

With that in mind, it’s ironic that, in the last four years, the United States Congress did not pass an infrastructure bill.

Nevertheless, even with (and maybe because of) the gridlock that looks to be in the country’s future, the infrastructure looks to be on the front burner again. The economic recovery is still far from complete. Unfortunately, neither are America’s roads, energy grid, telecommunications systems, and the like. That means that it would seem like a good policy for a Biden administration to look at an infrastructure bill.

Biden will be under pressure to endorse the $1.5 trillion infrastructure package that the Democrat-controlled House of Representatives passed in July. But the package may need to be tweaked a bit since it currently includes climate change initiatives that have kept the bill from advancing through the Senate.

However, it appears that the economy will need some significant juice after whatever this winter brings in terms of the virus. And if calmer heads prevail (we can always hope), there may be a major infrastructure bill to stimulate job creation. And we’ve identified seven stocks that should bear watching if this comes to pass.

View the "7 Infrastructure Stocks That May Help Rebuild America".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.